Liang Guanlin, Wen Tianfu, Mi Kai, Li Chuan, Wang Chuan, Li Kewei, Li Chen, Tang Yunhao
West China Hospital, Chengdu, China.
Hepatogastroenterology. 2012 Mar-Apr;59(114):364-5. doi: 10.5754/hge11554.
BACKGROUND/AIMS: To detect the feasibility of using synchronous bile duct, left lobe of liver and common hepatic artery resection without reconstruction to improve the therapeutic efficacy of HC.
A total of 19 patients with hilar cholangiocarcinoma undergoing left-sided hepatectomy, hepatic artery resection and right hepatic duct-jejunum anastomosis from June 2005 to May 2010 in our team were included prospectively in this study.
One case died from probable sudden myocardial infarction before discharge from hospital. Little bile leakage occurred in one case. No hepatic insufficiency developed in any cases. A follow-up of 6-66 months was applied and 11 cases were still alive at the end.
Hepatic Arteriectomy is viable with lower total bilirubin and the excision weight up to about 30% of the standard liver.
背景/目的：检测不进行重建而同步切除胆管、肝左叶和肝总动脉以提高肝门部胆管癌（HC）治疗效果的可行性。
2005年6月至2010年5月期间，本团队共19例接受肝左叶切除术、肝动脉切除术及右肝管-空肠吻合术的肝门部胆管癌患者被前瞻性纳入本研究。
1例患者在出院前可能因突发心肌梗死死亡。1例发生少量胆漏。所有病例均未出现肝功能不全。进行了6至66个月的随访，最终11例患者存活。
肝动脉切除术可行，总胆红素较低，切除重量可达标准肝脏的约30%。
